Subscribe
Subscribe
MY AMERICAN SCIENTIST
LOG IN! REGISTER!
SEARCH
 
Logo IMG
HOME > MULTIMEDIA > Multimedia Detail

SCIENCE IN THE NEWS DAILY

Erbitux OK for Colorectal Cancer Patients with Genetic Marker

from USA Today

A new study shows which colorectal cancer patients may benefit from a drug - and which would be better off without it.

The drug Erbitux doesn't work in patients whose tumor has a certain genetic mutation, according to a study of nearly 600 patients, presented Sunday at the annual meeting of the American Society of Clinical Oncology in Chicago.

About 36 percent of patients in the study have the mutation, in a gene called KRAS, says co-author Eric Van Cutsem, of University Hospital Gasthuisberg in Belgium. All of the patients in the study had colorectal cancer that had spread to other organs.

Read more ...


comments powered by Disqus
 

Connect With Us:

Facebook Icon Sm Twitter Icon Google+ Icon Pinterest Icon RSS Feed

Latest Multimedia

ANIMATION: Revealing the Logic Behind Candy Crush2014-11WalshF1.jpgClick to Enlarge Image

Candy Crush is turned into a model electrical circuit, which can be used to structure the equivalent of a logic puzzle. Besides justifying Candy Crush addictions, this information could be used to harness the player power of this game for bigger concerns, including computer security.
Watch the behind-the-scenes movements and how it is truly a logic puzzle.

To view all multimedia content, click "Latest Multimedia"!



RSS Feed Subscription

Receive notification when new content is posted from the entire website, or choose from the customized feeds available.


EMAIL TO A FRIEND :

Of Possible Interest

Science In The News Daily: Diesel Exhausts Do Cause Cancer, Says WHO

Science in the News Weekly: T-DM1 Treats Breast Cancer With Fewer Side Effects

Science In The News Daily: CT Scans on Children 'Could Triple Brain Cancer Risk'

Subscribe to American Scientist